Literature DB >> 7963424

Hepatitis C virus genotypes in France: comparison of clinical features of patients infected with HCV type I and type II.

D Qu1, J S Li, L Vitvitski, S Mechai, F Berby, S P Tong, F Bailly, Q S Wang, J L Martin, C Trépo.   

Abstract

Two major hepatitis C virus genotypes, F1 and F2, corresponding to hepatitis C virus type I and type II respectively, were found in France. To investigate the correlation between infection with these genotypes (F1 and F2) and clinical features of patients, serum samples proven to be hepatitis C virus positive by polymerase chain reaction amplification on 5' non-coding region were further amplified in the NS3 region with nested polymerase chain reaction. The NS3-polymerase chain reaction products were Southern blotted and hybridized with specific probes to identify the genotype of hepatitis C virus. Of 70 samples 64 were NS3-polymerase chain reaction positive. Twenty-eight (40%) samples were hepatitis C virus type I (F1) and 34 (49%) were hepatitis C virus type II (F2), while one sample (HB) hybridized with both probes and another (HN) hybridized with neither. Some samples were sequenced, with results consistent with those of hybridization. The HB sample was related more to hepatitis C virus type II than to type I and the HN sample was divergent from both type I and type II genotypes. Clinical profiles of patients infected with hepatitis C virus type I and type II were compared. Type I infected patients were younger (p < 0.01) and more often male (p < 0.05) than those of the type II group. Nine of 28 patients in the type I infected group had a history of drug abuse, whereas none did in the type II group. Five of 22 (23%) type I infected patients and 19 of 32 (59%) type II infected patients had cirrhosis (p < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7963424     DOI: 10.1016/s0168-8278(94)80139-8

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  13 in total

1.  Distribution of HCV genotypes among risk groups in Serbia.

Authors:  G Stamenkovic; S Zerjav; Z M Velickovic; K Krtolica; V L Samardzija; L Jemuovic; D Nozic; B Dimitrijevic
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  Predictors of response to interferon therapy.

Authors:  G Saracco; M Rizzetto
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

Review 3.  Hepatitis C virus: molecular biology and genetic variability.

Authors:  C Bréchot
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

4.  Genotyping hepatitis C virus isolates from Spain, Brazil, China, and Macau by a simplified PCR method.

Authors:  P V Holland; J M Barrera; M G Ercilla; C F Yoshida; Y Wang; G A de Olim; B Betlach; K Kuramoto; H Okamoto
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

5.  Analysis of hepatitis C virus isolates by serotyping and genotyping.

Authors:  L J van Doorn; B Kleter; I Pike; W Quint
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

Review 6.  Clinical significance of hepatitis C virus genotypes.

Authors:  N N Zein
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

7.  Correlation of genotypes and route of transmission with histologic activity and disease stage in chronic hepatitis C.

Authors:  F Ramalho; A Costa; A Pires; P Cabrita; F Serejo; A P Correia; N Fatela; H Clória; J Lopes; H C Pinto; R Marinho; M Raimundo; J Velosa; A Batista; M C de Moura
Journal:  Dig Dis Sci       Date:  2000-01       Impact factor: 3.199

Review 8.  Managing occupational risks for hepatitis C transmission in the health care setting.

Authors:  David K Henderson
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

9.  Genotypes and virus load in patients with hepatitis C infection.

Authors:  H Hofmann
Journal:  Infection       Date:  1995 May-Jun       Impact factor: 3.553

10.  Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study.

Authors:  Ali Kabir; Seyed-Moayed Alavian; Hussein Keyvani
Journal:  Comp Hepatol       Date:  2006-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.